Cognition Therapeutics CGTX Income Statement (2020-2026)

NASDAQ CGTX
$0.96 -0.02 (-2.26%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter)
3.67M6.52M8.27M5.43M8.50M11.67M11.60M10.55M11.58M11.39M-33.32M10.79M11.48M3.77M36.97M6.12M5.10M
Selling, General & Administrative (Quarter)
1.55M2.90M4.36M3.54M3.32M3.08M3.59M3.55M3.10M3.07M2.57M2.99M2.50M2.60M2.52M2.70M2.64M
Other Operating Expenses (Quarter)
-12.93M-39.82M
Operating Expenses (Quarter)
5.22M9.41M12.62M8.97M11.82M14.74M15.19M14.10M14.68M14.46M-43.69M13.78M13.98M6.38M-0.33M8.82M
Operating Income (Quarter)
-5.22M-11.81M-9.41M-12.62M-12.21M-8.97M-11.82M-14.74M-15.19M-14.10M-14.68M-14.46M-10.72M-13.78M-13.98M-6.38M-13.67M-8.82M
EBIT (Quarter)
-5.22M-11.81M-9.41M-2.16M-12.62M-12.21M-8.97M-11.82M-14.74M-15.19M-14.10M-14.68M-14.46M-10.72M-13.78M-13.98M-6.38M-13.67M-8.82M
Non-operating items
Other Non Operating Income (Quarter)
2.11M16.44M-0.20M6.00M12.23M2.80M7.09M8.00M7.05M0.24M0.33M4.53M2.88M5.29M0.14M1.45M-13.06M0.27M
Non Operating Income (Quarter)
-0.01M-0.00M-0.01M-0.01M-0.01M-0.00M-0.01M-0.01M-0.00M-0.01M-0.01M
Net income details
EBT (Quarter)
-27.44M-11.81M-3.71M-5.88M-14.28M-12.26M-6.17M-4.73M-15.48M-15.24M-15.62M-15.80M-15.12M-10.78M-13.83M-14.46M-6.80M-13.73M-8.87M
Tax Provisions (Quarter)
0.12M-0.12M
Profit After Tax (Quarter)
-3.11M-7.33M-3.84M-5.75M-6.62M-5.18M-6.17M-4.73M-6.75M-8.14M-9.15M-7.04M-9.94M-8.04M-8.48M-6.73M-4.93M-3.34M-4.57M
Income from Continuing Operations (Quarter)
-27.44M-11.81M-3.84M-5.75M-14.28M-12.26M-6.17M-4.73M-15.48M-15.24M-15.62M-15.80M-15.12M-10.78M-13.83M-14.46M-6.80M-13.73M-8.87M
Consolidated Net Income (Quarter)
-27.44M-11.81M-3.84M-5.75M-14.28M-12.26M-6.17M-4.73M-15.48M-15.24M-15.62M-15.80M-15.12M-10.78M-13.83M-14.46M-6.80M-13.73M-8.87M
Income towards Parent Company (Quarter)
-27.44M-11.81M-3.84M-5.75M-14.28M-12.26M-6.17M-4.73M-15.48M-15.24M-15.62M-15.80M-15.12M-10.78M-13.83M-14.46M-6.80M-13.73M-8.87M
Net Income towards Common Stockholders (Quarter)
-4.97M-11.81M-3.84M-5.75M-6.62M-12.26M-6.17M-4.73M-15.48M-15.24M-15.62M-15.80M-15.12M-10.78M-13.83M-14.46M-6.80M-13.73M-8.87M
Preferred Dividend Payments (Quarter)
1.86M
Additional items
EPS (Basic) (Quarter)
-8.12-2.27-0.17-0.25-0.29-0.52-0.21-0.16-0.51-0.51-0.46-0.39-0.37-0.27-0.22-0.23-0.09-0.19-0.10
EPS (Diluted) (Quarter)
-8.12-2.27-0.17-0.25-0.29-0.52-0.21-0.16-0.51-0.51-0.46-0.39-0.37-0.27-0.22-0.23-0.09-0.19-0.10
Shares Outstanding (Quarter)
0.61M5.19M22.43M22.60M23.02M23.64M29.09M29.61M30.37M30.03M33.74M40.06M40.42M39.73M61.83M63.69M77.95M72.77M89.19M
Shares Outstanding (Diluted) (Quarter)
0.61M5.19M22.43M22.60M23.02M23.64M29.09M29.61M30.37M30.03M33.74M40.06M40.42M39.73M61.83M63.69M77.95M72.77M89.19M
Shares Outstanding (Entity) (Quarter)
0.62M5.19M22.58M22.60M23.97M23.64M29.28M30.29M30.42M32.17M39.99M40.11M40.81M39.73M61.97M64.96M88.27M72.77M89.35M
EBITDA (Quarter)
-5.22M-11.81M-9.41M-2.16M-12.62M-12.21M-8.97M-11.82M-14.74M-15.19M-14.10M-14.68M-14.46M-10.72M-13.78M-13.98M-6.38M-13.67M-8.82M
Interest Expenses (Quarter)
22.21M5.95M3.72M1.65M0.05M2.08M1.51M0.74M0.06M1.51M1.12M0.66M0.06M0.06M0.48M0.42M0.06M0.05M
Tax Rate (Quarter)
-3.37%2.13%